\
&
Contact us
\
&
Contact us
Published on | 3 weeks ago
ProgrammesEIT Health has published the 2026 Transformative Healthcare Instrument call. It is designed to support high-potential European healthcare start-ups as they move product development forward, improve commercialisation plans and prepare for further fundraising. The programme focuses on unmet clinical needs across Europe.
Eligible applicants are private SMEs with at least 4 full-time equivalent employees and a minimum total equity investment of €2,000,000 closed within the previous 36 months, including at least one new investor. Projects must meet minimum Innovation Maturity Levels: IML 5 or above for biotech, IML 6 or above for medtech, and IML 7 or above for digital health and for biomarkers or diagnostics.
Projects may request €300,000 to €500,000 from EIT Health, covering up to 50% of total project costs, with the remaining 50% to come from other sources.
You can find further information about the call on this website. The call will close on 16 September 2026. An open Q&A session about the call is organised by EIT Health on 2 September at 11 am. Interested? Register here
Background: The European institute of Innovation and Technology (EIT) stands at the crossroad of business creation, innovation and education. It consists of ten knowledge and innovation communities, including the EIT health community. The overall objective is to transform promising innovations into succesful companies.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities.
The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.
